1333 related articles for article (PubMed ID: 17048973)
41. Predicting the "First dose in children" of CYP3A-metabolized drugs: Evaluation of scaling approaches and insights into the CYP3A7-CYP3A4 switch at young ages.
Strougo A; Yassen A; Monnereau C; Danhof M; Freijer J
J Clin Pharmacol; 2014 Sep; 54(9):1006-15. PubMed ID: 24676942
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetic predictions in children by using the physiologically based pharmacokinetic modelling.
Bouzom F; Walther B
Fundam Clin Pharmacol; 2008 Dec; 22(6):579-87. PubMed ID: 19049658
[TBL] [Abstract][Full Text] [Related]
43. Pharmacokinetics in renal failure.
Nancarrow C; Mather LE
Anaesth Intensive Care; 1983 Nov; 11(4):350-60. PubMed ID: 6359952
[TBL] [Abstract][Full Text] [Related]
44. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
45. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals.
Schlender JF; Meyer M; Thelen K; Krauss M; Willmann S; Eissing T; Jaehde U
Clin Pharmacokinet; 2016 Dec; 55(12):1573-1589. PubMed ID: 27351180
[TBL] [Abstract][Full Text] [Related]
46. Developmental Changes in Pharmacokinetics and Pharmacodynamics.
van den Anker J; Reed MD; Allegaert K; Kearns GL
J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S10-S25. PubMed ID: 30248190
[TBL] [Abstract][Full Text] [Related]
47. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
48. Semi-Mechanistic Model for Predicting the Dosing Rate in Children and Neonates for Drugs Mainly Eliminated by Cytochrome Metabolism.
Cerruti L; Bleyzac N; Tod M
Clin Pharmacokinet; 2018 Jul; 57(7):831-841. PubMed ID: 28889370
[TBL] [Abstract][Full Text] [Related]
49. Drug metabolism and pharmacokinetics in malnourished children.
Krishnaswamy K
Clin Pharmacokinet; 1989; 17 Suppl 1():68-88. PubMed ID: 2692941
[TBL] [Abstract][Full Text] [Related]
50. Factors influencing plasma drug concentrations.
Luscombe DK
J Int Med Res; 1977; 5(1 Suppl):82-97. PubMed ID: 863093
[TBL] [Abstract][Full Text] [Related]
51. Prediction of drug clearance in children.
Foissac F; Bouazza N; Valade E; De Sousa Mendes M; Fauchet F; Benaboud S; Hirt D; Tréluyer JM; Urien S
J Clin Pharmacol; 2015 Jul; 55(7):739-47. PubMed ID: 25721251
[TBL] [Abstract][Full Text] [Related]
52. Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged.
Schumacher GE
Am J Hosp Pharm; 1980 Apr; 37(4):559-62. PubMed ID: 6990755
[TBL] [Abstract][Full Text] [Related]
53. Knowledge-driven approaches for the guidance of first-in-children dosing.
Edginton AN
Paediatr Anaesth; 2011 Mar; 21(3):206-13. PubMed ID: 21129100
[TBL] [Abstract][Full Text] [Related]
54. [Pharmacokinetics and dosage regimen in children (author's transl)].
Gladtke E
Monatsschr Kinderheilkd (1902); 1979 Apr; 127(4):166-70. PubMed ID: 449872
[TBL] [Abstract][Full Text] [Related]
55. Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.
Alcorn J; McNamara PJ
Clin Pharmacokinet; 2002; 41(12):959-98. PubMed ID: 12222995
[TBL] [Abstract][Full Text] [Related]
56. Pharmacokinetic changes in aging.
Cohen JL
Am J Med; 1986 May; 80(5A):31-8. PubMed ID: 3518444
[TBL] [Abstract][Full Text] [Related]
57. Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation.
Han K; Peyret T; Quartino A; Gosselin NH; Gururangan S; Casanova M; Merks JH; Massimino M; Grill J; Daw NC; Navid F; Jin J; Allison DE
Br J Clin Pharmacol; 2016 Jan; 81(1):148-60. PubMed ID: 26345283
[TBL] [Abstract][Full Text] [Related]
58. Drug dosage in children with reduced renal function.
Daschner M
Pediatr Nephrol; 2005 Dec; 20(12):1675-86. PubMed ID: 16133064
[TBL] [Abstract][Full Text] [Related]
59. Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.
Zhou W; Johnson TN; Xu H; Cheung S; Bui KH; Li J; Al-Huniti N; Zhou D
CPT Pharmacometrics Syst Pharmacol; 2016 Sep; 5(9):475-83. PubMed ID: 27566992
[TBL] [Abstract][Full Text] [Related]
60. Changed pharmacokinetics under the influence of age.
Uges DR; Schootstra R
Pharm Weekbl Sci; 1987 Apr; 9(2):50-5. PubMed ID: 3295760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
